Cellular reprogramming, while holding immense potential for rejuvenation and regenerative medicine, is intrinsically linked to cellular senescence—a process that acts both as a barrier and a paradoxical facilitator.
This article addresses the critical challenge of dosage optimization for epigenetic modulators, a pivotal factor in translating their therapeutic promise into clinical success.
This article provides a comprehensive guide for researchers and drug development professionals on the critical challenge of optimizing cellular reprogramming duration.
This article provides a comprehensive analysis for researchers and drug development professionals on the critical challenge of controlling dedifferentiation in cellular rejuvenation therapies.
This article provides a comprehensive analysis for researchers and drug development professionals on leveraging epigenetic reprogramming to prevent cancer initiation.
This article comprehensively reviews the rapidly advancing field of chemical reprogramming, a non-genetic approach for generating human induced pluripotent stem cells (iPSCs) using small molecules.
This article provides a comprehensive analysis of the rapidly evolving field of biomaterial-mediated delivery of epigenetic modulators.
The extracellular matrix (ECM) is no longer viewed as merely a structural scaffold; its mechanical properties, particularly rigidity, are now recognized as potent regulators of the cellular epigenome.
This article explores the transformative role of three-dimensional (3D) microenvironments in enhancing the efficiency and functionality of cellular reprogramming.
This article provides a comprehensive analysis of current methods for delivering Yamanaka factors (OCT4, SOX2, KLF4, c-MYC) for in vivo reprogramming, a transformative approach in regenerative medicine.